Enrofloxacin should be cinoxacin and ceftiofur sodium should be cefotifosinate sodium for injection, both can be used in combination, and no relevant contraindications for combination are mentioned in drug interactions. 1. Cinoxacin: primary treatment of initial and recurrent urinary tract infections in adults caused by Escherichia coli, Klebsiella spp, Enterobacter spp, Proteus vulgaris, Proteus mirabilis, also suitable for prophylactic use in women with a history of recurrent urinary tract infections. Common adverse reactions to this product include nausea, headache, hypersensitivity reactions, and thrombocytopenia. Cenoxacin and aluminum thioglycollate are suspected to interact with each other in pharmacology and clinical practice, and may potentially exacerbate the patient’s condition or even require a change in therapy. 2. Cefthiophene sodium for injection: the main treatment of respiratory tract infections, sepsis, urinary tract infections, soft tissue infections caused by penicillin-resistant Staphylococcus aureus and sensitive gram-negative bacilli. Common adverse reactions include local pain, rash, allergy, granulocytopenia, gastrointestinal adverse reactions, and encephalopathy. There are contraindications with succinylcholine, methylphenidate, mesalamine, norepinephrine, lidocaine, benzylhydrazine hydrochloride, calcium chloride, soluble barbiturates, erythromycin gluconate, ciclosporin hydrochloride, delayed oxytetracycline, tetracycline hydrochloride, kanamycin, gentamicin, amikacin sulfate. With prochlorperazine, vitamin C, penicillin and other occasional contraindications, and furosemide, carazepam and other drugs may increase nephrotoxicity. It is recommended that patients who are unwell go to regular hospitals in a timely manner, and follow the doctor’s instructions for symptomatic treatment.